UBS O'Connor’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-105,000
Closed -$149K 457
2025
Q2
$149K Sell
105,000
-95,000
-48% -$7.58M ﹤0.01% 303
2025
Q1
$329K Buy
200,000
+150,000
+300% +$13.4M 0.01% 236
2024
Q4
$101K Sell
50,000
-20,000
-29% -$1.94M ﹤0.01% 348
2024
Q3
$106K Buy
+70,000
New +$6.88M ﹤0.01% 409
2024
Q2
Sell
-90,000
Closed -$232K 642
2024
Q1
$232K Buy
+90,000
New +$8.35M 0.01% 388
2023
Q3
Sell
-130,000
Closed -$268K 633
2023
Q2
$268K Sell
130,000
-10,000
-7% -$836K 0.01% 470
2023
Q1
$112K Buy
+140,000
New +$11.6M ﹤0.01% 530
2016
Q3
Sell
-22,500
Closed -$7K 503
2016
Q2
$7K Sell
22,500
-7,500
-25% -$411K ﹤0.01% 391
2016
Q1
$4K Buy
+30,000
New +$1.56M ﹤0.01% 428
2015
Q3
Sell
-55,200
Closed -$13K 747
2015
Q2
$13K Buy
+55,200
New +$4.29M ﹤0.01% 730

Other funds holding XBI